211-GS
Endothelial Cell Growth Supplement (15ml)
Sinônimo(s):
Primary Cell Culture Media Supplement
Faça loginpara ver os preços organizacionais e de contrato
About This Item
Código UNSPSC:
12352207
NACRES:
NA.71
Produtos recomendados
forma
liquid
Nível de qualidade
prazo de validade
1 yr
fabricante/nome comercial
Cell Applications, Inc
Condições de expedição
dry ice
temperatura de armazenamento
−20°C
Categorias relacionadas
Descrição geral
Added to Basal Medium to create Growth Medium
Human endothelial cell growth supplement is added to the basal medium to create growth medium. The complete growth medium (equivalent to Cat# 211-500) is optimized and best-suited for angiogenesis and other physiological studies.
Aplicação
Endothelial Cell Growth Supplement (15ml) has been used as a supplement for culturing:
- human type II alveolar cells
- human umbilical vein endothelial cells (HUVEC)
- human pulmonary artery endothelial cells (HPAECs)
Qualidade
Each lot was tested for the ability to support plating, spreading and proliferation
Nota de preparo
contained in protocol
Código de classe de armazenamento
10 - Combustible liquids
Classe de risco de água (WGK)
WGK 3
Certificados de análise (COA)
Busque Certificados de análise (COA) digitando o Número do Lote do produto. Os números de lote e remessa podem ser encontrados no rótulo de um produto após a palavra “Lot” ou “Batch”.
Já possui este produto?
Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.
Os clientes também visualizaram
Michelle V Mouritzen et al.
Journal of peptide science : an official publication of the European Peptide Society, 24(7), e3093-e3093 (2018-06-26)
Neurotensin, substance P, and insulin have been demonstrated to improve wound healing in vivo. However, the mechanism behind their effect is still not fully understood. This study investigates the effects leading to enhanced scratch closure by these peptides in vitro.
Koustav Ganguly et al.
Scientific reports, 10(1), 20460-20460 (2020-11-26)
Limited toxicity data on electronic cigarette (ECIG) impede evidence-based policy recommendations. We compared two popular mixed fruit flavored ECIG-liquids with and without nicotine aerosolized at 40 W (E-smoke) with respect to particle number concentrations, chemical composition, and response on physiologically relevant
Hong Xue et al.
International journal of chronic obstructive pulmonary disease, 16, 1329-1345 (2021-05-20)
Etanercept (ETN), a tumor necrosis factor-α (TNF-α) inhibitor, has been applied in the treatment of many diseases. However, whether it has effects on chronic obstructive pulmonary disease (COPD) and its interaction with tumor necrosis factor receptor 1 (TNFR1) remained unknown.
Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.
Entre em contato com a assistência técnica